In summary, miR‐103 could suppress the expression of TRPV3 by binding to the 3′ UTR, thereby reducing relative fluorescence intensity of Ca2+ signal, leading to the decrease in the activation of cardiac autophagy and ultimately inhibiting the development of cardiac hypertrophy (schematized in Figure 8). The gene discussed is TRPV3; the disease is cardiac hypertrophy.